Clinical Study Report (CSR)

A Clinical Study Report (CSR) is a comprehensive document that summarizes the results of a clinical trial. The CSR provides detailed information about the trial design, conduct, and outcome, and serves as a key source of information for regulatory authorities, scientific communities, and the general public. The main components of a CSR typically include:

1. Executive summary: A brief overview of the trial design, conduct, and outcome.
2. Study design: A detailed description of the trial design, including the study population, study interventions, and outcome measures.
3. Conduct of the trial: Information about the recruitment, randomization, and follow-up of the trial participants.
4. Demographic and baseline data: A summary of the demographic and baseline data of the trial participants.
5. Study results: A comprehensive presentation of the trial results, including statistical analysis and interpretation of the data.
6. Adverse events: A summary of the adverse events that occurred during the trial, including serious adverse events and adverse events leading to withdrawal.
7. Conclusions: A summary of the main conclusions of the trial, including the efficacy and safety of the study drug.
8. References: A list of the relevant literature and references cited in the CSR.

The CSR is usually prepared by the sponsor of the trial and is submitted to the relevant regulatory authorities as part of the marketing authorization application. The CSR is also used by scientific communities, health care providers, and the general public to make informed decisions about the use of the study drug. The CSR should be prepared in accordance with the relevant regulatory guidelines and should provide a complete and accurate picture of the trial results.

You may be interested in the programs below: